SEC Filings

PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/27/2019
Entire Document

Schedule 4.6(b)




1.U.S. ex. Rel. Conrad v. Abbott Labs, Inc., et al. (U.S.D.C. Mass.).


2.State of Louisiana v. Abbott Laboratories, Inc., et al. (U.S.D.C., M.D. La.).


3.GlaxoSmithKline Arbitration.


4.Medicine to Go Pharmacies, Inc. v. Macoven Pharmaceuticals, L.L.C. and Pernix Therapeutics Holdings, Inc., District Court of New Jersey (10/23/16).


5.Presswood v. Pernix Therapeutics Holdings, Inc., Circuit Court of St. Louis County, Missouri (3/18/15).


6.Pernix Ireland Pain, Ltd. and Pernix Therapeutics, LLC v. Actavis Laboratories FL, Inc., District of Delaware Case No. 16-138; Pernix Ireland Pain, Ltd. and Pernix Therapeutics, LLC v. Alvogen Malta Operations, Ltd., District of Delaware Case No. 16-139.


7.Ghirsig Employment Dispute (EEOC Claim).


8.Beginning in 2014 and continuing to the present, a number of pharmaceutical companies have been named in numerous lawsuits brought by certain state and local governments related to the marketing of opioid pain medications, including, UFCW Local 23 Health Fund v. Endo Pharmaceuticals, Inc., et al., Iron Workers Dist. Council of Philadelphia & Vicinity, Benefit Fund v. Abbott Laboratories, Inc., et al. and certain matter brought by the State of Arkansas against the Seller (collectively, the “Opioid Litigations”).


9.Navigators Insurance Company v. Pernix Therapeutics Holdings, Inc. (U.S. District Court, Eastern District of PA).


10. Pernix Therapeutics Holdings, Inc. - FINRA Matter No: 20180608629.


11.Musachia v Pernix (U.S.D.C., N.D. Alabama).


Schedule 4.6(b)